Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
Sci Rep
.
2021 Dec 20;11(1):24423.
doi: 10.1038/s41598-021-04066-1.
Authors
Sara Moufarrij
#
1
2
,
Aneil Srivastava
#
1
3
,
Stephanie Gomez
1
3
4
,
Melissa Hadley
1
3
,
Erica Palmer
1
5
,
Paul Tran Austin
1
3
,
Sarah Chisholm
1
3
,
Noor Diab
1
,
Kyle Roche
1
3
,
Angela Yu
1
3
,
Jing Li
1
5
,
Wenge Zhu
1
5
,
Micael Lopez-Acevedo
1
2
,
Alejandro Villagra
6
7
,
Katherine B Chiappinelli
8
9
Affiliations
1
The George Washington University Cancer Center, The George Washington University, Washington, DC, USA.
2
The Department of Obstetrics & Gynecology, The George Washington University, Washington, DC, USA.
3
The Department of Microbiology, Immunology, & Tropical Medicine, The George Washington University, Washington, DC, USA.
4
The Institute for Biomedical Sciences, The George Washington University, Washington, DC, 20052, USA.
5
The Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA.
6
The George Washington University Cancer Center, The George Washington University, Washington, DC, USA. avillagra@gwu.edu.
7
The Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA. avillagra@gwu.edu.
8
The George Washington University Cancer Center, The George Washington University, Washington, DC, USA. kchiapp1@gwu.edu.
9
The Department of Microbiology, Immunology, & Tropical Medicine, The George Washington University, Washington, DC, USA. kchiapp1@gwu.edu.
#
Contributed equally.
PMID:
34931014
PMCID:
PMC8688520
DOI:
10.1038/s41598-021-04066-1
No abstract available
Publication types
Published Erratum